Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, Geospiza Merge Data-Visualization and Pathway-Analysis Tools for NGS Research

Premium

Ingenuity and Geospiza will integrate their Ingenuity Pathway Analysis and GeneSifter software products to create a research workflow for next-generation sequence data analysis and visualization, Ingenuity said this week.

Ingenuity's Chief Scientific Officer and Chief Technology Officer Doug Basset said the partnership aims to help joint customers answer research questions by "providing a streamlined way for researchers to move from a list of genes, isoforms, or variants all the way to identifying drug targets, validating biomarkers, generating hypotheses, and understanding drug mechanism of action."

The partners hope that the combined tools will speed up drug discovery and –omics research by enabling researchers to "visualize their data in the context of known biological processes, functions, diseases, pathways and relationships," said Geospiza Chief Technology Officer Todd Smith.

Ingenuity recently merged IPA with California-based TransMed Systems' XB Bio-Integration Suite — a data analytics and management tool that lets users capture, analyze, visualize, and share their genomic data as well as access multiple genomic data sources, create patient cohorts, and generate hypotheses

The combined platform is expected to enable users to collect and analyze pre-clinical and clinical data in the context of signaling and metabolic pathways, networks, and cellular processes that are available in IPA (BI 10/22/2010).

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.